Professor, Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine
Psychiatry
Dr. Susan B. McElroy, DO
Susan McElroy practices Psychiatry. She went to Weill Cornell Medical College of Cornell University. Weill Cornell Medical College of Cornell University is ranked 18 in research and 49 in primary care medicine Susan B. McElroy, DO has written publications. She has 101 publications published with PubMed. The lastest publication is: 'Baseline disability and poor functioning in bipolar disorder predict worse outcomes: results from the Bipolar CHOICE study.'
Publications
- A tool to predict suicidal ideation and behavior in bipolar disorder: The Concise Health Risk Tracking Self-Report.
- Prevalence and correlates of DSM-5 eating disorders in patients with bipolar disorder.
- Baseline disability and poor functioning in bipolar disorder predict worse outcomes: results from the Bipolar CHOICE study.
- Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): a pragmatic 6-month trial of lithium versus quetiapine for bipolar disorder.
- Longitudinal Modeling The Effect Of Lisdexamfetamine Dimesylate And Changes In Binge Eating Frequency On Disability In Patients With Binge Eating Disorder.
- Longitudinal Modeling Of The Relationship Between Lisdexamfetamine Dimesylate And Health-Related Quality Of Life In Adults With Moderate To Severe Binge Eating Disorder.
- Sex differences in the risk of rapid cycling and other indicators of adverse illness course in patients with bipolar I and II disorder.
- Association of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism with early-onset bipolar disorder.
- Psychopharmacologic treatment of eating disorders: emerging findings.
- Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder: a randomized clinical trial.
- Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE).
- Clinical risk factors and serotonin transporter gene variants associated with antidepressant-induced mania.
- Psychotherapy use in bipolar disorder: Association with functioning and illness severity.
- Complexity of Illness and Adjunctive Benzodiazepine Use in Outpatients With Bipolar I or II Disorder: Results From the Bipolar CHOICE Study.
- Adjunctive lisdexamfetamine in bipolar depression: a preliminary randomized, placebo-controlled trial.
- Placebo Cessation in Binge Eating Disorder: Effect on Anthropometric, Cardiovascular, and Metabolic Variables.
- Verbal abuse, like physical and sexual abuse, in childhood is associated with an earlier onset and more difficult course of bipolar disorder.
- Bipolar disorder with comorbid binge eating history: A genome-wide association study implicates APOB.
- Relationship of clinical course of illness variables to medical comorbidities in 900 adult outpatients with bipolar disorder.
- Corrigendum to "Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II disorder: Results from the...
- Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II disorder: results from the Bipolar CHOICE ...
- More Medical Comorbidities in Patients With Bipolar Disorder From the United States Than From the Netherlands and Germany.
- Metabolic syndrome in bipolar disorder: a review with a focus on bipolar depression.
- Placebo Response in Binge Eating Disorder: A Pooled Analysis of 10 Clinical Trials from One Research Group.
- Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): A pragmatic trial of complex treatment for a complex disorder.
- Genome-wide association study of bipolar disorder accounting for effect of body mass index identifies a new risk allele in TCF7L2.
- A randomized, double-blind, placebo-controlled study of ziprasidone monotherapy in bipolar disorder with co-occurring lifetime panic or generalized anxiety disorder.
- Heritability and linkage analysis of personality in bipolar disorder.
- Increased parental history of bipolar disorder in the United States: association with early age of onset.
- Association of exercise with quality of life and mood symptoms in a comparative effectiveness study of bipolar disorder.
- Zonisamide in the treatment of bulimia nervosa: An open-label, pilot, prospective study.
- Heritability and genome-wide SNP linkage analysis of temperament in bipolar disorder.
- Clinical phenotype of bipolar disorder with comorbid binge eating disorder.
- Association of dopamine transporter gene variants with childhood ADHD features in bipolar disorder.
- Characteristics of responders and non-responders to risperidone monotherapy or placebo in co-occurring bipolar disorder and anxiety disorder.
- Adjunctive Methylphenidate in the Treatment of Bulimia Nervosa Co-occurring with Bipolar Disorder and Substance Dependence.
- Randomized, placebo-controlled trial of quetiapine XR and divalproex ER monotherapies in the treatment of the anxious bipolar patient.
- A placebo-controlled pilot study of the novel opioid receptor antagonist ALKS-33 in binge eating disorder.
- Role of childhood adversity in the development of medical co-morbidities associated with bipolar disorder.
- N-acetylcysteine in bulimia nervosa - open-label trial.
- Binge eating disorder in elderly individuals.
- Current pharmacotherapy options for bulimia nervosa and binge eating disorder.
- Bulimia nervosa presenting as rectal purging and rectal prolapse: Case report and literature review.
- Duloxetine in the treatment of binge eating disorder with depressive disorders: A placebo-controlled trial.
- Pharmacogenomics of antidepressant induced mania: A review and meta-analysis of the serotonin transporter gene (5HTTLPR) association.
- A double-blind, placebo-controlled trial of topiramate for pathological gambling.
- Sodium oxybate in the treatment of binge eating disorder: an open-label, prospective study.
- Acamprosate in the treatment of binge eating disorder: a placebo-controlled trial.
- Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder.
- Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood.
- Gender and depressive symptoms in 711 patients with bipolar disorder evaluated prospectively in the Stanley Foundation bipolar treatment outcome network.
- Longitudinal study of the diagnosis of components of the metabolic syndrome in individuals with binge-eating disorder.
- Randomized, double-blind, placebo-controlled study of divalproex extended release loading monotherapy in ambulatory bipolar spectrum disorder patients with moderate-to...
- Suggestive evidence for linkage of ADHD features in bipolar disorder to chromosome 10p14.
- Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study.
- Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression.
- Obesity in patients with severe mental illness: overview and management.
- Treating bipolar disorder in the primary care setting: the role of aripiprazole.
- Suggestive linkage of a chromosomal locus on 18p11 to cyclothymic temperament in bipolar disorder families.
- Olanzapine in the treatment of pathological gambling: a negative randomized placebo-controlled trial.
- Co-occurrence of binge eating disorder with psychiatric and medical disorders.
- Understanding the complexity of bipolar mixed episodes.
- Bipolar mixed episodes: characteristics and comorbidities.
- Substance use disorders and overweight/obesity in bipolar I disorder: preliminary evidence for competing addictions.
- A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression.
- The poor prognosis of childhood-onset bipolar disorder.
- Psychiatric and metabolic characteristics of childhood versus adult-onset obesity in patients seeking weight management.
- Atomoxetine in the treatment of binge-eating disorder: a randomized placebo-controlled trial.
- Awareness of metabolic concerns and perceived impact of pharmacotherapy in patients with bipolar disorder: a survey of 500 US psychiatrists.
- Binge eating disorder: a stable syndrome.
- Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial.
- Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder.
- Subsyndromal depressive symptoms are associated with functional impairment in patients with bipolar disorder: results of a large, multisite study.
- A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression.
- Suggestive evidence for association of the circadian genes PERIOD3 and ARNTL with bipolar disorder.
- Binge-eating disorder as a distinct familial phenotype in obese individuals.
- Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropio...
- Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants.
- Pharmacologic treatment considerations in co-occurring bipolar and anxiety disorders.
- Mixed hypomania in 908 patients with bipolar disorder evaluated prospectively in the Stanley Foundation Bipolar Treatment Network: a sex-specific phenomenon.
- Relationship of mania symptomatology to maintenance treatment response with divalproex, lithium, or placebo.
- Comparison of rapid-cycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients.
- Open-label adjunctive zonisamide in the treatment of bipolar disorders: a prospective trial.
- Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression.
- Preliminary observations on the effectiveness of levetiracetam in the open adjunctive treatment of refractory bipolar disorder.
- Topiramate in the long-term treatment of binge-eating disorder associated with obesity.
- Correlates of 1-year prospective outcome in bipolar disorder: results from the Stanley Foundation Bipolar Network.
- Bipolar disorders: special diagnostic and treatment considerations in women.
- Are mood disorders and obesity related? A review for the mental health professional.
- Psychiatric and legal features of 113 men convicted of sexual offenses.
- A 52-week, open-label continuation study of lamotrigine in the treatment of bipolar depression.
- Depression, anxiety, anger, and somatic symptoms in patients with body dysmorphic disorder.
- Diagnosing and treating comorbid (complicated) bipolar disorder.
- Zonisamide in the treatment of binge-eating disorder: an open-label, prospective trial.
- Bipolar disorder, obesity, and pharmacotherapy-associated weight gain.
- Olanzapine versus placebo in acute mania: treatment responses in subgroups.
- Maintenance efficacy of divalproex in the prevention of bipolar depression.
- Psychosis in bipolar disorder: phenomenology and impact on morbidity and course of illness.
- Citalopram in the treatment of binge-eating disorder: a placebo-controlled trial.
- Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method.
Schools
West Virginia School of Osteopathic Medicine
Western Pennsylvania Hospital
Doctors Specialties
- Osteopathic Manipulative Therapy
- Psychiatry
Accepted Insurances
Education
-
New York Presbyterian Hospital - Columbia Campus -
Weill Cornell Medical College of Cornell University